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Abstract. 
 
a
 
5-deficient mice die early in embryogenesis 
(Yang et al., 1993). To study the functions of 
 
a
 
5 inte-
grin later in mouse embryogenesis and during adult life 
we generated 
 
a
 
5 
 
2
 
/
 
2
 
;
 
1
 
/
 
1
 
 chimeric mice. These ani-
mals contain 
 
a
 
5-negative and positive cells randomly 
distributed. Analysis of the chimerism by glucose-
6-phosphate isomerase (GPI) assay revealed that
 
a
 
5 
 
2
 
/
 
2
 
 cells contributed to all the tissues analyzed. 
High contributions were observed in the skeletal mus-
cle. The perinatal survival of the mutant chimeras was 
lower than for the controls, however the subsequent life 
span of the survivors was only slightly reduced com-
pared with controls (Taverna et al., 1998). Histological 
analysis of 
 
a
 
5 
 
2
 
/
 
2
 
;
 
1
 
/
 
1
 
 mice from late embryogenesis 
to adult life revealed an alteration in the skeletal mus-
cle structure resembling a typical muscle dystrophy. Gi-
ant fibers, increased numbers of nuclei per fiber with al-
tered position and size, vacuoli and signs of muscle 
degenerationÐregeneration were observed in head, tho-
rax and limb muscles. Electron microscopy showed an 
increase in the number of mitochondria in some muscle 
fibers of the mutant mice. Increased apoptosis and im-
munoreactivity for tenascin-C were observed in mutant 
muscle fibers. All the alterations were already visible at 
late stages of embryogenesis. The number of altered 
muscle fibers varied in different animals and muscles 
and was often increased in high percentage chimeric 
animals. Differentiation of 
 
a
 
5 
 
2
 
/
 
2
 
 ES cells or myo-
blasts showed that in vitro differentiation into myo-
tubes was achieved normally. However proper adhe-
sion and survival of myoblasts on fibronectin was 
impaired. Our data suggest that a novel form of muscle 
dystrophy in mice is 
 
a
 
5-integrin-dependent.
Key words: muscular dystrophy ¥ chimeric mice ¥ in-
tegrin 
 
a
 
5
 
b
 
1 ¥ apoptosis
 
T
 
he
 
 interactions of extracellular matrix (ECM)
 
1
 
 com-
ponents with each other or with cell surface recep-
tors have an important role in many biological pro-
cesses such as embryonic development, wound healing,
malignant transformation and many others (Hynes, 1990,
1992; Ruoslahti, 1991; Hynes and Lander, 1992; Giancotti
and Mainiero, 1994). CellÐECM interactions are mediated
by cell surface receptors called integrins. Integrins are
transmembrane glycoproteins which consist of noncova-
lently linked heterodimers each composed of an 
 
a
 
 and a
 
b
 
 chain (Hynes, 1992).
 
a
 
5
 
b
 
1 integrin is a specific receptor, which binds to the
arginine/glycine/aspartic acid region of one of the most
common ECM molecules, fibronectin (FN) (Pytela et al.,
1985). 
 
a
 
5
 
b
 
1 is involved in many cellular processes includ-
ing cell proliferation and oncogenic transformation (Plan-
tefaber and Hynes, 1989; Giancotti and Ruoslahti, 1990;
Schreiner et al., 1991), cell survival (Varner et al., 1995;
Zhang et al., 1995), cell migration (Akiyama et al., 1989;
Giancotti and Ruoslahti, 1990), assembly of FN-rich ma-
trices (Fogerty et al., 1990), wound healing (Guo et al.,
1991), T cell activation (Shimizu and Shaw, 1991), and gene
expression (Werb et al., 1989). It also plays an important
role during embryogenesis (Yang et al., 1993). Indeed, the
 
a
 
5 subunit is expressed at high levels during embryogene-
sis in 
 
Xenopus
 
 (Whittaker and De Simone, 1993), chicken
(Muschler and Horwitz, 1991) and mouse (Goh et al.,
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1. 
 
Abbreviations used in this paper
 
:
 
 
 
ECM, extracellular matrix; ES, embry-
onic stem; FN, fibronectin; GPI, glucose-6-phosphate isomerase; H&E,
hematoxylin and eosin; LM, laminin; MTJ, myotendinous junction;
PTAH, phosphotungstic acid haematoxylin; TN-C, tenascin-C; WT, wild-
type.
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1997); its expression is more restricted in adult tissues
(Muschler and Horwitz, 1991).
Development of skeletal muscle is a multistep process
that starts when the somitic mesoderm differentiates into
the dermamyotome. Soon after that, primary myoblasts
proliferate and migrate to their peripheral locations where
they differentiate into postmitotic multinucleated myo-
tubes, the primary myotubes (primary fusion). The migra-
tion of secondary myoblasts that align with the primary
myotubes leads to the formation of secondary myotubes
(secondary fusion). Finally the myotubes specialize as fast
or slow contracting fibers and become striated and inner-
vated (Kelly and Rubinstein, 1994). Several adhesion mol-
ecules, integrins, cadherins, and immunoglobulin super-
family members are thought to be involved in myogenesis
(Knudsen et al., 1990). The extracellular matrix of skeletal
muscle consists of a basal lamina around every myotube
and interstitial connective tissue (endomysium) between
the fibers. Collagens and fibronectins are abundant in the
endomysium whereas the basal lamina contains type IV
collagen, laminin, heparan sulfate proteoglycan, entactin
(nidogen), and fibronectins (Sanes, 1994). 
 
a
 
 and 
 
b
 
 integrin
subunits are expressed on skeletal muscle cells at different
times and subcellular locations. 
 
a
 
1, 
 
a
 
3, 
 
a
 
5, 
 
a
 
6, and 
 
a
 
v are
highly expressed during muscle development and down-
regulated after full differentiation (Bronner-Fraser et al.,
1992; Duband et al., 1992; Enomoto et al., 1993; Mc-
Donald et al., 1995). 
 
a
 
7 integrin is abundant through all
stages of muscle development (Bao et al., 1993), whereas
 
a
 
4 integrin expression rises during secondary myogenesis
then is not expressed anymore (Rosen et al., 1992). 
 
a
 
v sub-
unit is concentrated at the costameres and at the myoten-
dinous junction (MTJ); 
 
a
 
3 is localized to the MTJ whereas
 
a
 
5 is present in adhesion plaque-like structures along the
myotube. 
 
a
 
7 is concentrated at the MTJ but can also be
detected at the neuromuscular junction and along the sar-
colemmal membrane. The 
 
b
 
1 subunit is present on myo-
blasts and on muscle fibers along the entire membrane
with maximum concentrations at the MTJ and costameres
or Z discs (Bozyczko et al., 1989).
A key question is what are the functions of these various
integrins in muscle biology? One way to address this ques-
tion is via genetic elimination of specific integrins. 
 
a
 
5-defi-
cient mice die at approximately day 10 or 11 of gestation
(Yang et al., 1993). The null embryos have pronounced de-
fects in posterior trunk and yolk sac mesodermal struc-
tures. No somites, a kinky neural tube, and vascular de-
fects are observed in the posterior end. To study the
functions of the 
 
a
 
5 molecule after day 10 or 11 and in adult
animals, we generated 
 
a
 
5 
 
2
 
/
 
2
 
 embryonic stem (ES) cells
and injected them into wild-type (WT) blastocysts to ob-
tain 
 
a
 
5 
 
2
 
/
 
2
 
;
 
1
 
/
 
1
 
 chimeric animals. Here we present data
on the characterization of these chimeras.
 
Materials and Methods
 
Growth, Selection, and Differentiation of ES Cells
 
ES cells, D3 line (Doetschman et al., 1985), were grown as described pre-
viously (George et al., 1993). 
 
a
 
5 heterozygous ES cells were obtained as
described in Yang et al. (1993). One heterozygous 
 
a
 
5 ES cell line, clone
47, was expanded and selected with 4Ð5 mg/ml G418 (GIBCO BRL,
Gaithersburg, MD). After 7Ð9 d of selection, drug-resistant clones were
picked and expanded on feeder cells. Half of the cells from each clone
were frozen in 10% DMSO in fetal bovine serum and half were lysed for
extraction and analysis of DNA. From three independent selection exper-
iments 5 clones that were null for 
 
a
 
5 from Southern blot analysis were ob-
tained (154, 162, 194, 201, and 305). Further Southern blot analysis of one
of these clones (154) also showed that the vicinity of the mutated genomic
region was not altered during the selection (data not shown). Some het-
erozygous clones that did not become null after G418 selection were used
as control clones (152, 155, 98) as well as D3 wild-type cells and ES cells
heterozygous for
 
 
 
P
 
 
 
and E selectins (Robinson et al., 1997). All these cells
had characteristics of wild-type cells.
To generate chimeric mice, ES cells were prepared and injected into
C57BL6 blastocysts as described by George et al. (1993) and Bradley et al.
(1987). Chimeric progeny were identified by coat color 1 wk after birth.
Before and around birth the animals were screened by PCR for the pres-
ence of the neo gene and by glucose-6-phosphate isomerase assay (see be-
low). Differentiation of ES cells followed the protocol of Yang et al.
(1996). The embryoid bodies were analyzed for muscle differentiation af-
ter 15Ð30 d of culture in a leukemia inhibitory factorÐfree medium. Differ-
entiated cultures were stained with an antibody against skeletal muscle
myosin heavy chain (MY32; Sigma Chemical Co., St. Louis, MO) as de-
scribed (Yang et al., 1996).
 
DNA Extraction, Southern Blot, and PCR Analysis
 
DNA was extracted from ES cells or myoblasts as described in Yang et al.
(1996). Southern blot analyses were performed as described in Yang et al.
(1993). PCR analysis for the neo gene was performed on tail DNA as de-
scribed in Taverna et al. (1998).
 
Glucose-6-Phosphate Isomerase Analysis of Tissue
 
Glucose-6-phosphate isomerase (GPI) analysis was performed on extracts
of different tissues, e.g., limb or pectoral muscle, as described in Yang et al.
(1996). Densitometric analysis of the GPI assays was performed using ei-
ther 1 D-multilane scan or Spot Denso scan of the IS-1000 Digital Imaging
System (Alpha Innotech, San Leandro, CA). The percentage of ES cell-
derived (129Sv) isoform of GPI was calculated as described in Yang et al.
(1996).
 
Histological Analysis
 
Pregnant mothers were killed towards the end of pregnancy and embry-
onic day E16ÐE18 embryos were analyzed. Embryos, newborns, 1Ð4 wk-
old mice, or several month-old animals were killed in a CO
 
2
 
 chamber,
opened ventrally and dorsally, and then the opened carcasses were im-
mersed in 10% formalin (3.7% formaldehyde in phosphate-buffered sa-
line) and kept in fixative until processed. In some cases embryos or new-
borns were cut transversely into four portions, each portion embedded in
mounting medium (OCT compound; Miles Laboratories, Elkhart, Milwau-
kee, WI) and immediately frozen in liquid nitrogen-cooled isopentane. 6-
 
m
 
m
sections were cut. The same freezing procedure was used to generate sec-
tions from dissected limb or pectoral muscle of adult mice. Transverse or
longitudinal paraffin-embedded or frozen sections were processed for he-
matoxylin and eosin (H&E) or phosphotungstic acid hematoxylin (PTAH)
staining according to the supplierÕs protocol (Sigma Chemical Co.).
 
Apoptosis
 
Apoptotic cells were analyzed in the animals using terminal transferase bi-
otinylated-dUTP nick-end labeling (TUNEL) on paraffin sections from
E17 or E18 formalin-fixed embryos as described by Morganbesser et al.
(1995). To analyze apoptosis in vitro, myoblasts (see below) were plated
on mouse laminin-1 (GIBCO BRL) or FN for 2 h before being trypsinized
and resuspended in buffer containing 1 
 
m
 
g/ml annexin-FITC as described
by the manufacturerÕs protocol (Zymed, South San Francisco, CA). After
a 10-min incubation, the cells were washed, stained with 1 
 
m
 
g/ml Hoechst
33342, and then mounted on a slide. In five separate fields, both the total
number of cells and the number of annexin-positive cells were counted.
 
Immunohistochemistry
 
To analyze ECM molecules, 6-
 
m
 
m paraffin-embedded or frozen sections
from E18 embryos were used. Frozen sections were also used to analyze
the distribution of 
 
a
 
5 integrin. Paraffin-embedded sections from overnight
formalin-fixed embryos were treated with trypsin (0.1%) for 30 min at 
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room temperature and then stained as described in George et al. (1993).
Frozen sections from unfixed embryos were stained with the same proto-
col except that they were not pretreated with trypsin and the incubations
were shortened to 15 min for primary and secondary antibodies. Primary
antibodies were used at 1:100 dilution: rabbit polyclonal anti-LM (Sigma
Chemical Co.); rabbit polyclonal anti-collagen IV (Becton Dickinson Lab-
ware, Franklin Lakes, NJ); rabbit polyclonal anti-entactin (nidogen), a gift
of A. Chung (University of Pittsburgh, Pittsburgh, PA); rabbit 24 poly-
clonal anti-FN (Mautner and Hynes, 1977); rat monoclonal antiÐtenas-
cin-C (Sigma Mtn-12; Sigma Chemical Co.); rat monoclonal anti 
 
a
 
5 inte-
grin (PharMingen, San Diego, CA). Secondary antibodies were used at
1:200 dilution of FITC-conjugated goat antiÐrabbit or antiÐrat (Biosource
International, Camarillo, CA).
 
Isolation of Myoblasts
 
Limb muscles from neonatal chimeric mice (
 
2
 
/
 
2
 
;
 
1
 
/
 
1
 
 or 
 
1
 
/
 
2
 
;
 
1
 
/
 
1
 
) were
dissociated to isolate pure populations of myoblasts as described in Rando
and Blau (1994). Primary cultures were plated on laminin-1Ðcoated dishes
and grown in growth medium consisting of HamÕs F-10 nutrient mixture
(BioWhittaker, Walkersville, MD), 20% fetal bovine serum (FBS) (Bio-
Whittaker), 2.5 ng/ml basic fibroblast growth factor (bFGF) (Promega
Corp., Madison, WI), and penicillin (200 U/ml)/streptomycin (200 
 
m
 
g/ml)
(GIBCO BRL). ES cell-derived myoblasts were purified by maintaining
the cells in G418 (50 
 
m
 
g/ml) for at least 2 wk. To induce differentiation,
myoblast cultures were maintained in medium consisting of DulbeccoÕs
modified EagleÕs medium supplemented with 2% horse serum and peni-
cillin/streptomycin. For analysis of differentiation of each cell population,
the differentiated cultures were fixed with MeOH (
 
2
 
20
 
8
 
C) and stained
with Hoechst (1 
 
m
 
g/ml). The fusion index was determined microscopically
as the ratio of the number of nuclei in cells with three or more nuclei to
the total number of nuclei. 10 random fields in each of three separate cul-
tures were counted at 40
 
3 
 
magnification, with each field having between
50 and 100 nuclei.
 
Retroviral Infection
 
a
 
5 cDNA was introduced into 
 
a
 
5-deficient myoblasts by retroviral-medi-
ated gene transfer (Guan et al., 1990) using a human 
 
a
 
5 cDNA insert (Ar-
graves et al., 1987). Retroviral infection of myoblast populations was per-
formed as described previously (Rando and Blau, 1994). To ensure a high
level of infection, cells were infected on three successive days, which gives
 
.
 
90% infection (Rando and Blau, 1997). To control for the infection pro-
cedure, 
 
a
 
5-deficient myoblasts were infected with a retrovirus lacking a
cDNA insert. Expression of 
 
a
 
5 in retrovirally transduced cells was exam-
ined by Western blot analysis (see below).
 
Cell Adhesion
 
Cells were plated on 5 
 
m
 
g/ml LM-1, 5 
 
m
 
g/ml FN (both from GIBCO
BRL), or collagen type I (100 
 
m
 
g/ml; Sigma Chemical Co.) and allowed to
attach for 1 h at 37
 
8
 
C. Unattached cells were removed by washing. Adher-
ence was then assessed by hemacytometer counts of attached cells after
trypsinization.
 
Western Blot Analysis
 
Myoblasts were lysed in RIPA buffer. Proteins (50 
 
m
 
g) were electrophore-
sed on 7.5% SDS-PAGE gels under nonreducing conditions then trans-
ferred to nitrocellulose membranes (Schleicher & Schuell, Inc., Keene,
NH). The membranes were probed with an antibody to 
 
a
 
5 integrin (1:5,000;
Chemicon, Temecula, CA) followed by a peroxidase-linked donkey antiÐ
rabbit secondary antibody (1:10,000; Amersham Corp., Arlington Heights,
IL). The enhanced chemiluminescence (ECL) system was used to visual-
ize the bound secondary antibody.
 
Results
 
Generation of Chimeric Mice
 
ES cells heterozygous for 
 
a
 
5 integrin were selected in the
presence of high concentrations of G418 (4Ð5 mg/ml) to
obtain homozygous clones. Southern blot analysis indi-
cated that five different 
 
a
 
5 2/2 ES cell clones were gener-
ated (Fig. 1). The five clones were injected into WT
C57BL6 blastocysts. Control chimeras were produced by
injecting clones heterozygous for a5 integrin or for P and
E selectins (Robinson et al., 1997) or WT ES cells (D3)
into WT C57BL6 blastocysts. Chimeric animals had both
black (from C57BL6) and agouti (from 129Sv-derived ES
cells) coat color.
For embryos and newborns the chimerism was deter-
mined by PCR analysis for the neo gene (Taverna et al.,
1998) in combination with a GPI assay for quantitation
(Yang et al., 1996). The chimerism in adults was evaluated
by the coat color. A representative population of chimeric
animals obtained using a5 2/2 or control ES cells was the
following (Table I): at day 17 or 18 of pregnancy, 56% (76
out of 135) of the C57BL6 blastocysts injected with five in-
dependent a5 2/2 clones developed as chimeric embryos,
whereas only 22% (31 out of 139) of the C57BL blasto-
cysts injected with control ES cells (D3 or a5 1/2 clones)
developed as chimeric embryos. The number of embryos
Figure 1. Southern Blot analysis of ES cells for a5 integrin.
Clone 152, an a5-heterozygous clone of ES cells; both the wt (6.6-
kb) and the mutated (8.4-kb) bands are present. 162, 194, 154,
305, four independent homozygous ES cell clones. Only the mu-
tated band is present.
Table I. Generation and Survival of a5 2/2;1/1
Chimeric Mice
Clone
Blastocysts
injected
Chimeras at
E17-E18
Chimeras at
weaning
a5 2/2 (5 clones) 135 76 (56%) Ñ
a5 6 or D3 (wt) 139 31 (22%) Ñ
a5 2/2 (5 clones) 205 Ñ 37 (18%)
a5 6 or D3 (wt) 258 Ñ 39 (15%)
Table II. Percentage Contributions of a5 2/2 Cells to Tissues 
of Chimeric Mice
Chimeras
Tissue
Percentage ES cell contribution to chimeras
Control ES cells a5 2/2 ES cells
123456789 1 0 1 1 1 2 1 3
Lung 30 10 10 50 30 10ÑÑÑÑÑÑ2 0
Liver 10 10 30 50 10 40ÑÑÑÑ1 02 01 5
Spleen 60 50 30 50 80 50 30ÑÑÑ1 05 06 0
Kidney 60 50 50 80 30 30ÑÑÑÑ2 04 05 0
Brain 10 10ÑÑ4 03 0ÑÑÑÑÑÑÑ
G u t 5 05 0ÑÑ4 03 04 0ÑÑÑÑÑÑ
Heart 60 10 50 65 50 Ñ 30ÑÑ8 01 05 02 0
Diaphragm 10 10 5 60 50 50ÑÑÑ 5Ñ4 07 0
Limb muscle 90 90 30 80 80 90 90 80 90 80 80 80 80
Pectoral muscle 90 90 Ñ 80 90 90 Ñ 80 90 80 Ñ 80 80
Coat color* 95 90 40 98 90 90 95 95 95 90 90 98 95
*Judged by eye; Ñ, not done.The Journal of Cell Biology, Volume 143, 1998 852
in uterus (chimeric and nonchimeric) was similar in both
kind of injections; therefore the higher number of a5 2/2;
1/1 chimeric embryos indicates a better contribution of
a5 2/2 ES clones in the blastocysts; i.e., the null ES clones
are highly competent, more so than the parent and control
ES cells, presumably as a result of the subcloning involved
in their selection. In contrast, at weaning (4-wk-old ani-
mals) 18% (37 out of 205) of a5 2/2;1/1 and 15% (39 out
258) of control chimeras were observed. The marked de-
crease of a5 2/2;1/1 chimeras from 56% at E17 or E18
to 18% at weaning suggests that not all the chimeras
present in uterus or born can survive. Indeed we found
that many a5 2/2;1/1 newborn chimeras died within the
24 h after delivery. The lower survival rate for a5-null chi-
meras suggested requirements for a5 integrin in the peri-
natal development of certain tissues or organs.
Developmental Capacities of a5-null ES Cells
The chimerism of various tissues was analyzed by GPI as-
say in adult animals (see Table II). The contribution of
129Sv cells in some organs was lower than expected from
Figure 2. Morphology of skeletal muscle in a5 2/2;1/1 chimeric mice. (AÐC) Transverse sections of muscles from E18 chimeric em-
bryos: (A) control thoracic, (B) mutant thoracic, and (C) mutant limb muscles. Giant fibers, central nuclei, vacuoles, and size variability
can be observed in the mutant muscles. (DÐF) Longitudinal sections of muscles from E18 chimeric embryos: (D) control thoracic mus-
cle, (E) mutant head, and (F) mutant thorax muscles. Increase of collagen among fibers (E) and degeneration of fibers (F) appear in
mutant muscles. (GÐI) Transverse sections of head muscle of 9-d-old animals: (G) control and (H and I) mutants. Mutant muscles show
a high variability in fiber size, increased connective tissue, central nuclei, and fiber degradation. (JÐL) Transverse sections of limb mus-
cle of adults: (J) control and (K and L) mutants. Note the presence of central nuclei (K) and ring fibers (L) in mutant chimeras. D and I
are PTAH stained, all others are H&E stained. Bar, 50 mm.Taverna et al. a5 Integrin in Skeletal Muscle 853
coat color in both mutant and control chimeras. This was
probably due to a disadvantage of 129Sv cells in specific
organs. However the a5-null cells contributed equally as
well as did the control ES cells (Table II). We analyzed the
populations of mature 129Sv-derived T and B lympho-
cytes by FACS¨ analysis and observed equal contributions
in mutant and in control chimeras (data not shown). Clone
154 was tested for germ-line transmission of the a5-null al-
lele: germline transmission was obtained from both a male
and a female chimera indicating the presence of both a5
2/2 sperm and oocytes. We conclude that a5 2/2 cells
contribute to all tissues analyzed, albeit in somewhat dif-
ferent percentages.
Muscle Defects in Animals Chimeric for a5
Histological analysis of E16ÐE18 embryos, newborns,
young, and adult animals revealed no major defects. The
chimeras were normal in size, weight, and appearance and
showed no obvious defects in behavior (walking, climbing,
swimming, or mating). The only defects we detected con-
sistently were structural alterations in skeletal muscles.
Approximately 40% of the 150 a5 2/2;1/1 chimeric em-
bryos and newborn animals analyzed showed abnormal
skeletal muscles in the head, thorax, or limb (i.e., muscles
derived from several different embryonic originsÑneural
crest, lateral mesoderm, somites). Chimerism varying from
10 to 90% was observed for both a5 2/2;1/1 chimeras
and control animals. Embryos with the most noticeable al-
terations had high chimerism as evaluated by GPI analysis
of either the upper portion of the right posterior leg (in-
cluding cartilage, muscle, and skin) or the dissected limb
muscle of that leg. Examples of these alterations are illus-
trated in Fig. 2. Fig. 2, B and C show transverse sections
through the thorax (B) or limb (C) of E18 a5 2/2;1/1
chimeric embryos and they illustrate irregularity in the
sizes of the fibers with presence of giant fibers, central nu-
clei, and vacuoles. Increased collagen deposition between
fibers and fiber degeneration were also observed in muscle
from E18 a5 2/2;1/1 chimeric embryos (Fig. 2, E and F).
Sections of the thoracic muscles of control E18 embryos
(Fig. 2, A and D) showed good regularity in the muscle
structure and no fiber degeneration or collagen accumula-
tion could be observed. Analysis of a5 2/2;1/1 chimeras
in the first month after birth confirmed the presence of
muscle degeneration and regeneration in the skeletal mus-
cles. Fig. 2, H and I show examples of degeneration in the
head muscles of a 9-d-old chimera. Variability in fiber size,
central nuclei, empty spaces in the fibers, and increase of
connective tissue (especially evident in Fig. 2 I with PTAH
staining) were observed. A control muscle is shown in Fig.
2 G. Signs of muscle degenerationÐregeneration were still
visible in some adult animals (several months old). Many
fibers with central nuclei (Fig. 2 K, limb) ring fibers indica-
tive of fiber degeneration and regeneration (Fig. 2 L,
limb) and infiltration of adipose tissue (data not shown)
were found in head, thorax, and limb muscles. Control
limb muscle is shown in Fig. 2 J. The diaphragms and the
heart of a5 2/2;1/1 chimeric mice appeared normal at all
stages (data not shown), perhaps because the heart and di-
aphragm generally showed a lower 129Sv (ES cell) contri-
bution than other muscles for both 2/2 and control chi-
meras (Table II). Alternatively, it is possible that mice
with a high percentage of a5 2/2 cells in the diaphragm
are among those that die early. Ultrastructural analysis of
limb muscle of E17 embryos revealed an increase in the
number of mitochondria in some fibers of mutant chimeric
mice (Fig. 3, B and C) compared with control chimeras
(Fig. 3 A). It is possible that the fibers with more mito-
chondria correspond to the giant fibers we observed by
histology.
The distribution of a5 integrin in mutant and control
embryos was investigated by immunohistochemistry. a5
integrin immunoreactivity was found around each muscle
fiber and at some MTJ in control animals (Fig. 4, A and
B). In mutant embryos a conspicuous decrease of a5 inte-
grin staining was found around many muscle fibers; how-
ever, fibers completely negative for a5 were rare (Fig. 4 C)
due to the fact that null and wild-type myoblasts fuse to-
gether.
The composition of the ECM in the muscles of chimeric
mice was analyzed by immunohistochemistry. Fibronectin,
the ligand for a5b1 integrin, was present around and be-
tween all the fibers of both mutant and control chimeras.
No major, consistent differences in intensity were ob-
served between giant- and regularly sized fibers of mutant
Figure 3. Electron micrographs of limb muscle. Limb muscles from E17 control (A) and a5 2/2;1/1 chimeras (B and C) are shown. An
increase in the number of mitochondria is observed in some fibers of the mutant chimeras (B and C). Bar, 500 nm.The Journal of Cell Biology, Volume 143, 1998 854
only at the MTJ and on the nerves crossing the muscle
(Chiquet and Fambrough, 1984). The analysis of TN-C in
E17 or E18 embryos showed an enhanced deposition of
TN-C around and between some muscle fibers of a5 2/2;
1/1 chimeric embryos compared with controls (Fig. 5 A),
suggesting a similar process of degenerationÐregeneration
as in other myopathies.
In mdx/mdx dystrophic mice, degeneration of fibers is
sometimes preceded by apoptosis (Matsuda et al., 1995;
Sandri et al., 1995; Tidball et al., 1995). We investigated
whether the same is true in a5 2/2;1/1 chimeric mice.
Fig. 5 B shows that, although almost no apoptosis was ob-
served in E18 control chimeras, some E18 mutant animals
(seven out of 10 chosen at random) showed an increase of
apoptotic fibers in various muscles (Fig. 5 B, dark fibers).
Myogenesis In Vitro in the Absence of a5 Integrin (ES 
Cells and Myoblasts)
Our in vivo data suggest that muscle differentiation can
occur even in almost complete absence of a5-positive myo-
blasts (GPI of the limb z95%). However, long-term integ-
rity of the muscle is compromised. We examined the abil-
ity of a5-null ES cells to differentiate into myoblasts and
myotubes. Three null and two heterozygous (control) ES
cell clones were grown in suspension to produce embryoid
bodies. The embryoid bodies were then plated on gelatin-
coated coverslips to induce differentiation. The differenti-
ated cultures were stained with an antibody against skele-
tal muscle myosin heavy chain. 42% of the wells (19 out of
45) with a5-null embryoid bodies (all three clones) and
28% of the wells (14 out of 50) with control embryoid bod-
ies stained positively. The degree of differentiation (fu-
sion, myosin expression) appeared similar in control and
mutant cultures (Fig. 6 A).
To test further the role of a5 integrin in muscle cell ad-
hesion, growth, differentiation, and survival we isolated
primary myoblast cultures from control and mutant chi-
meric mice. Myoblasts derived from a5-null or heterozy-
gous ES cells were selected by culture in G418. The purity
of the cell populations was analyzed by Southern blot
analysis (data not shown) (Yang et al., 1993, 1995) and the
expression of a5 integrin was analyzed by Western blot
analysis (Fig. 7 A). Control (1/2) myoblasts expressed a5
integrin whereas a5-null myoblasts were negative for a5
expression (Fig. 7 A). When maintained in low-serum me-
dium, both control (1/2) and mutant (2/2) myoblasts
differentiated into multinucleated myotubes (Fig. 6 B),
and the rate and extent of myotube formation was similar
in the two populations (Fig. 6 C). Control and a5-deficient
myoblasts grown on laminin-1 had similar doubling times
(data not shown) and displayed similar morphologies (Fig.
7  B). However, the phenotypes of the two populations
were very different when plated on fibronectin, the ligand
for the a5b1 integrin receptor. Whereas a5-expressing
cells attached and spread readily on fibronectin, a5-defi-
cient cells adhered poorly, showed very little spreading,
and displayed a rounded morphology, typical of poor cellÐ
substrate adherence (Fig. 7, B and C). As further evidence
that the different substrate requirements were indeed due
to a5 deficiency (and not to some other property of the
a5-deficient cell population), we restored a5 expression to
Figure 4. a5 integrin expression in muscle. Transverse (A and C)
and longitudinal (B) sections of thoracic muscle from E18 control
(A and B) and mutant (C) chimeric embryos were stained for a5
integrin. a5 integrin is expressed around the muscle fibers (A)
and at the myotendinous junctions (MTJ) in control animals,
while it is weakly expressed or missing around some fibers in mu-
tant animals (C). Bar, 50 mm.
chimeras (data not shown). The basement membrane com-
ponents, nidogen (entactin), collagen IV, and laminin-1
were also analyzed and no differences in staining were ob-
served between mutant and control chimeras (data not
shown). Expression of tenascin-C (TN-C) has been corre-
lated with muscle regeneration in several muscular dystro-
phies (Settles et al., 1995). In normal muscle it is presentTaverna et al. a5 Integrin in Skeletal Muscle 855
the a5-deficient cells by retrovirus-mediated gene transfer.
A control population of a5-deficient cells was infected
with a retrovirus expressing only the neo gene. Expression
of a5 in rescued cells (but not in control infected cells) was
confirmed by Western blot analysis (Fig. 7 A). The res-
cued cells appeared to adhere as well to fibronectin as did
wild-type cells (Fig. 8, A and B).
Because of the apoptosis we observed in vivo (Fig. 5 B)
and since interference with integrin-mediated adhesion
has been reported to cause apoptosis (Frisch and Francis,
1994; Zhang et al., 1995; Goh et al., 1997), we tested for
apoptosis in the myoblasts cultured on various substrates.
Whereas a5-expressing cells showed similar percentages
of annexin-positive cells on fibronectin or laminin-1, a5-
deficient cells showed a fourfold increase in annexin-posi-
tive cells on fibronectin compared with laminin-1 (Fig. 9).
Clearly, the absence of a5 expression increases the pro-
pensity of the cells to undergo apoptotic cell death when
FN is the major component of the ECM.
Discussion
The results presented here show that a5-null cells can par-
ticipate in a wide variety of differentiative processes; ani-
mals with a high degree of chimerism in many organs sur-
vive and reproduce. The only defect which we observed
consistently in chimeric animals containing a significant
proportion of a5-null cells was a novel form of muscular
dystrophy. This allowed us to focus on the differentiation
and survival of muscle cells and tissues and the depen-
dence of these processes on a5b1 integrin.
Earlier results have shown blockade of migration of
myoblasts and of their differentiation into myotubes by in-
hibitory antibodies against various integrin subunits, in-
cluding b1 (Jaffredo et al., 1988; Menko et al., 1987), a4
(Rosen et al., 1992) or a7 (Echtermeyer et al., 1996; Yao
et al., 1996). However, in vitro differentiation of ES cells
and myoblasts lacking b1 or a4 proceeds normally (Yang
et al., 1996; Brakebush et al., 1997) and b1-null and a4-null
cells can participate in myogenesis in chimeric mice
(Faessler and Meyer, 1995; Yang et al., 1996). In the ex-
periments reported here, we obtained similar results for
a5-null cells. In vitro, neither a5-null ES cells nor a5-null
myoblasts showed any deficit in myogenesis and, in chi-
meric mice, muscles with a high proportion of a5-null cells
could form. These results demonstrate that a5b1 integrin
is not essential for the proliferation, migration, or differen-
tiation of myoblasts, myotubes, and skeletal muscles.
However, in contrast with the results for a4-null chimeras
(Yang et al., 1996), we observed a significant level of ab-
normalities in the skeletal muscles of the a5-null chimeras
(Figs. 2Ð4). These muscles showed many characteristics of
muscular dystrophy, including giant fibers, central nuclei,
vacuoles, fibrosis, and fiber degeneration. Later in life we
observed signs of regeneration such as ring fibers. We also
observed increased apoptosis and ectopic expression of
TN-C (Fig. 5) as has been reported for other forms of mus-
cular dystrophy (Settles et al., 1996).
These results are reminiscent of the observations of
Mayer et al. (1997) on a7 integrin-deficient mice, which
also exhibit muscular dystrophy, and of recent reports of
deficiencies in a7b1 in human and murine muscular dys-
trophies (Hodges et al., 1997; Mayer et al., 1997; Vachon
et al., 1997). It appears that these two integrins, a5b1 and
a7b1, one a receptor for fibronectin and the other a recep-
Figure 5. Muscle lesionÐasso-
ciated phenotypes: tenas-
cin-C  (TN-C) expression and
apoptosis. (A) Transverse
sections of thoracic muscle
from E18 mutant or control
chimeric embryos were
stained for tenascin-C. Sec-
tions from control animals
show TN-C staining in the
nerve (center) crossing the
muscle and at the MTJ (up-
per left), but the muscle itself
is negative. In contrast, ten-
ascin is found distributed
around muscle fibers in the
mutant embryos and is not
restricted to the MTJ. (B)
Terminal transferase biotiny-
lated-dUTP nick-end label-
ing (TUNEL) analysis in
transverse sections of tho-
racic muscles from mutant
or control E18 embryos is
shown. More apoptotic cells
are observed in mutant chi-
meras. Bars, 50 mm.The Journal of Cell Biology, Volume 143, 1998 856
tor for laminin, are both necessary for long-term integrity
of myotubes, although not for their initial development.
a5 is found localized at adhesion plaques (McDonald
et al., 1995) and at the MTJ (Fig. 4); a7 is concentrated at
the MTJ (McDonald et al., 1995) where tendons attach.
Because these two integrins are present at the points in the
fibers where mechanical stress occurs, it suggests an an-
choring function of these molecules. Two Drosophila mu-
tants show a similar situation; in myospheroid and inflated
(mutations affecting integrin subunits) muscle differentia-
tion occurs in the absence, respectively, of bPS or aPS2 in-
tegrins; however, on contraction, the muscles detach from
their attachments (Volk et al., 1990; Brabant et al., 1993).
We can imagine that, in the absence of a7b1 or a5b1, im-
portant points of adhesion are lost or weakened and there-
fore contraction leads to damage to the myotubes. The in-
crease in the number of mitochondria in some fibers of the
a5 2/2;1/1 chimeric mice could suggest that, when the fi-
bers cannot function normally, they tend to hypercontract
and they need more ATP that requires the formation of a
higher number of mitochondria. Other possibilities for the
increase in mitochondria include altered differentiation
and compensation for the reduced level of a5 integrin.
It is noteworthy that many forms of muscular dystrophy
arise from defects in connections to the extracellular ma-
trix. That includes the classical muscular dystrophies aris-
ing from defects in dystrophin and its transmembrane link-
age via dystroglycans to laminins and in the laminins
Figure 6. ES cell and myoblast differentiation into myotubes. (A) Differentiated
a5 1/2 and a5 2/2 ES cell cultures were stained for skeletal muscle myosin
heavy chain and counterstained with hematoxylin (nuclear staining). In both cul-
tures, multinucleated differentiated myotubes are present. (B) Myotube forma-
tion by a5 1/2 and a5 2/2 myoblasts plated on laminin and maintained in differ-
entiation medium for 5 d. (C) Fusion index was determined for a5 1/2 and a5 2/2
myoblast cultures after 3 and 5 d in differentiation medium. No significant differ-
ences were observed between the two cell populations.Taverna et al. a5 Integrin in Skeletal Muscle 857
themselves (Campbell, 1995). The novel form of muscular
dystrophy which we describe here differs from the others,
including those caused by a7 integrin deficiencies, in hav-
ing no obvious connection with laminins. a5b1 has no
affinity for laminins and is believed to be specific for
fibronectin. The a5-null myoblasts show defects in adher-
ence and survival on fibronectin substrates but behave
normally on laminin (Fig. 7).
The fact that the muscle defect of the a5-chimeric mice
is visible at a very early age (embryonic and postnatal life)
and is more attenuated later in life might be due to the
high expression, and probable importance, of a5 in embry-
onic and postnatal muscle followed by later downregula-
tion (McDonald et al., 1995). In vitro data show that over-
expression of a5b1 in myoblasts promotes proliferation
and inhibits differentiation, suggesting a proliferative func-
tion of this integrin (Sastry et al., 1996). It is possible that,
in the chimeras, a5 is particularly important when a high
rate of proliferation is occurring. However, since our mice
are chimeras and the muscle fiber is a fusion of a5-null and
wild-type cells we cannot exclude the possibility that the
defect is partially rescued by the presence of wild-type
cells. Another possible reason for amelioration of the phe-
notype in later life could be gradual replacement of a5-
null cells by wild type during regeneration. Consistent with
this possibility is the appearance of ring fibers in the older
muscles, indicating some fiber regeneration.
We favor the hypothesis that the dystrophy arises from
defects in the myofibers themselves, as discussed above. In
particular, the time of onset during fetal life corresponds
with the period when a5b1 is known to be strongly ex-
pressed in muscle cells and the parallels with the muscle
defects seen in Drosophila integrin mutants are suggestive.
However, we cannot rule out the possibility that defects or
deficits in other a5-null cells, such as interstitial fibro-
blasts, neurons or Schwann cells or vascular endothelial
cells, could contribute to the phenotype observed. We do
know that a5-null fibroblasts can assemble FN matrix and
migrate and adhere normally (Yang and Hynes, 1996) and
proliferate normally in vitro (Goh, K.L., and R.O Hynes,
unpublished data) which argues against a causal defect in
fibroblasts without eliminating that possibility.
The reasons for the degenerative changes observed in
the muscles deficient in a5b1 remain unclear, as indeed is
the case for other muscular dystrophies. Several possible
explanations can be imagined. As mentioned above, if
a5b1 (and a7b1) are important for maintaining mechani-
cal connections between the myotubes and adjacent struc-
tures (e.g., tendons), disruption of the weakened linkage
under contraction is a likely initiating cause. Perhaps less
likely in this case is a general weakening of the cell surface
structure comprising submembranous cytoskeleton con-
nected to the basal lamina. Another possibility is that the
apoptosis (Fig. 5) could be a causative event rather than a
Figure 7. Myoblast adhesion on different substrates. (A) Western blot analysis of
a5 integrin expression in different cell populations. RV, retrovirus-mediated gene
transfer. (B) Morphology of a5 1/2 and a5 2/2 cells plated on laminin or fi-
bronectin for 1 h. On fibronectin, a5 2/2 cells displayed a rounded morphology
indicative of poor adherence. (C) Relative adhesion of a5 2/2 and a5 1/2 myo-
blasts plated on different substrates for 1 h. Data are presented as mean 6 SD
from four separate experiments, each performed in duplicate.The Journal of Cell Biology, Volume 143, 1998 858
secondary consequence. Precedent exists for cellsÕ being
dependent on specific integrin-matrix adherence for cell
survival (Zhang et al., 1995) and such dependences include
dependence on a5b1Ðfibronectin interactions (Zhang et al.,
1995). However, our in vitro data somewhat argue against
this idea without ruling it out. The a5-null myoblasts do in-
deed show increased apoptosis when plated on fibronectin
but do not when plated on laminin (Fig. 9). Myotubes are
surrounded by a basal lamina rich in laminin, although
also containing fibronectin. Thus, although it is possible
that adherence to fibronectin via a5b1 is specifically nec-
essary for myotube survival, it seems more likely that any
such requirement for attachment to basal lamina is satis-
fied by connection to laminin via a7b1 or via dystrogly-
cans. Whatever the detailed causeÐeffect relationships
leading to fiber degeneration and muscular defects in the
mice, the results reported here reveal a novel form of mus-
cular dystrophy.
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Figure 8. Phenotypic rescue of a5-deficient myoblasts by retrovirus-mediated
gene transfer of the a5 gene (a5 integrin expression is shown in Fig. 7 A). (A) a5
2/2 cells into which a5 has been introduced by retrovirus-mediated gene transfer
(a5 2/2 (RV- a5)) were plated on fibronectin for 1 h. Unlike the a5 2/2 cells
(see B), the a5 2/2 (RV-a5) cells adhered well to fibronectin and were indistin-
guishable from the control cells (a5 1/2). (B) Quantitative adhesion assay dem-
onstrates that expression of a5 integrin by retrovirus-mediated gene transfer (a5
2/2 (RV- a5) cells) restores normal adhesion to FN in the a5 2/2 cells. Infection
of a5 2/2 cells with a control retrovirus expressing only the neo gene (a5 2/2
(RV-neo) cells) did not restore normal adherence.
Figure 9. Myoblast survival on fibronectin versus laminin. Apop-
tosis in a5 1/2, a5 2/2, and a5 2/2 (RV-a5) cells plated on FN
or LM was determined by annexin staining (see Materials and
Methods). Data are presented as percentages of apoptotic cells
on FN compared with that on LM for each cell type. Whereas the
percentage of apoptosis in a5 1/2 and a5 2/2 (RV-a5) were
similar on the two substrates, there was increased apoptosis of
a5 2/2 cells on fibronectin compared with laminin.Taverna et al. a5 Integrin in Skeletal Muscle 859
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